Benedetta Puccini

1.8k total citations
56 papers, 804 citations indexed

About

Benedetta Puccini is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Benedetta Puccini has authored 56 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pathology and Forensic Medicine, 19 papers in Neurology and 19 papers in Oncology. Recurrent topics in Benedetta Puccini's work include Lymphoma Diagnosis and Treatment (52 papers), CNS Lymphoma Diagnosis and Treatment (19 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Benedetta Puccini is often cited by papers focused on Lymphoma Diagnosis and Treatment (52 papers), CNS Lymphoma Diagnosis and Treatment (19 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Benedetta Puccini collaborates with scholars based in Italy, United States and Ukraine. Benedetta Puccini's co-authors include Luigi Rigacci, Alberto Bosi, Flavia Salvi, Luca Vaggelli, Annalisa Chiappella, Umberto Vitolo, Alberto Fabbri, Pier Luigi Zinzani, Barbara Botto and Marco Ladetto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Benedetta Puccini

53 papers receiving 796 citations

Peers

Countries citing papers authored by Benedetta Puccini

Since Specialization

Citations

This map shows the geographic impact of Benedetta Puccini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benedetta Puccini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benedetta Puccini more than expected).

Fields of papers citing papers by Benedetta Puccini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benedetta Puccini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benedetta Puccini. The network helps show where Benedetta Puccini may publish in the future.

Co-authorship network of co-authors of Benedetta Puccini

This figure shows the co-authorship network connecting the top 25 collaborators of Benedetta Puccini. A scholar is included among the top collaborators of Benedetta Puccini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benedetta Puccini. Benedetta Puccini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Cost-Effectiveness Analysis of Mosunetuzumab vs Tisagenlecleucel for Treatment of Third- or Higher-Line (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL) in Italy 2025 ·ClinicoEconomics and Outcomes Research ·(unknown), Antonio Pinto, Benedetta Puccini, (unknown), Emanuela Omodeo Salè, (unknown), Lorenzo Pradelli, (unknown)	1
2	Texture analysis of 18F‐FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement 2024 ·Hematological Oncology ·(unknown), Flavia Linguanti, (unknown), Vittorio Miele, Francesco Mungai, (unknown), Luca Nassi, Benedetta Puccini, Ilaria Romano, Benedetta Sordi, (unknown), Gabriele Simontacchi, Alessandro M. Vannucchi, Valentina Berti	6
3	Waveline-007: Dose Escalation and Confirmation, and Efficacy Expansion Trial of Zilovertamab Vedotin in Combination with Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab in Patients with Diffuse Large B Cell Lymphoma 2024 ·Blood ·Muhıt Özcan, Eva González‐Barca, Tae Min Kim, Ewa Paszkiewicz‐Kozik, Jan Maciej Zaucha, Stefan Hohaus, Marco Ladetto, Caterina Patti, Sebastian Giebel, Tadeusz Robak, Ömür Gökmen Sevindik, Yulia Volchek, Benedetta Puccini, (unknown), Raúl Córdoba, (unknown), (unknown), (unknown), Rushdia Z. Yusuf, David Lavie	1
4	New treatment options in elderly patients with Diffuse Large B-cell Lymphoma 2023 ·Frontiers in Oncology ·Annalisa Arcari, Federica Cavallo, Benedetta Puccini, Daniele Vallisa	9
5	Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques 2023 ·Cancers ·(unknown), M. Barbetti, Flavia Linguanti, Francesco Mungai, Luca Nassi, Benedetta Puccini, Ilaria Romano, Benedetta Sordi, Raffaella Santi, Alessandro Passeri, (unknown), C. Talamonti, Angelina Cistaro, Alessandro M. Vannucchi, Valentina Berti	15
6	Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) 2023 ·Annals of Hematology ·Emanuele Cencini, Ilaria Romano, (unknown), (unknown), (unknown), (unknown), Lara Mannelli, (unknown), (unknown), (unknown), Giulia Cervetti, Emanuela Sant’Antonio, Federico Simonetti, (unknown), Benedetta Puccini, Monica Bocchia, Alberto Fabbri	1
7	Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience 2022 ·Translational Oncology ·Manuela Capone, Benedetta Peruzzi, Boaz Palterer, Sara Bencini, Alessandro Sanna, Benedetta Puccini, Luca Nassi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Roberto Caporale, Francesco Annunziato	11
8	18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis 2021 ·Journal of Personalized Medicine ·Tetiana Skrypets, Cristina Ferrari, Luca Nassi, Gloria Margiotta Casaluci, Benedetta Puccini, Lara Mannelli, (unknown), (unknown), (unknown), Maria Carmela Vegliante, Antonella Daniele, G. Sacchetti, Attilio Guarini, Carla Minoia	2
9	Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience 2021 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), Anna Marina Liberati, Luigi Rigacci, Benedetta Puccini, Alessandro Pulsoni, Guido Gini, Piero Galieni, Alberto Fabbri, Maria Cantonetti, Vincenzo Pavone, Silvia Bolis, Barbara Botto, Daniela Renzi, Lorenzo Falchi	3
10	A Gene Expression–based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma Patients 2019 ·Clinical Cancer Research ·Stefano Luminari, Benedetta Donati, Massimiliano Casali, Riccardo Valli, Raffaella Santi, Benedetta Puccini, Sofya Kovalchuk, (unknown), Angelo Famà, Valentina Berti, Valentina Fragliasso, Magda Zanelli, Federica Vergoni, Annibale Versari, Luigi Rigacci, Francesco Merli, Alessia Ciarrocchi	11
11	Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study 2019 ·Annals of Hematology ·Luigi Rigacci, Benedetta Puccini, Alessandro Broccoli, (unknown), Manuel Gotti, Andrea Evangelista, Armando Santoro, Maurizio Bonfichi, Alessandro Re, Michele Spina, Barbara Botto, Alessandro Pulsoni, Chiara Pagani, Caterina Stelitano, Flavia Salvi, Luca Nassi, Lara Mannelli, Sofya Kovalchuk, Daniela Gioia, Pier Luigi Zinzani	3
12	The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma 2019 ·Scientific Reports ·Alberto Magi, Marika Masselli, (unknown), Angela Guerriero, Pasquale Laise, Benedetta Puccini, Luigi Rigacci, (unknown), Olivia Crociani, Serena Pillozzi, Annarosa Arcangeli	21
13	Role of bone marrow biopsy in staging of patients with classical Hodgkin’s lymphoma undergoing positron emission tomography/computed tomography 2017 ·Annals of Hematology ·(unknown), Benedetta Puccini, Luca Nassi, Carla Minoia, Stefano Volpetti, Rosanna Ciancia, (unknown), Alice Di Rocco, Antonino Mulè, (unknown), (unknown), Roberto Guariglia, (unknown), Erica Finolezzi, (unknown), Silvia Zanon, Anna Furlan, (unknown), Francesco Zaja	11
14	Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 2013 ·Leukemia & lymphoma ·Stefania Nobili, Cristina Napoli, Benedetta Puccini, Ida Landini, Gabriele Perrone, Marco Brugia, G. Benelli, (unknown), Maurizio Martelli, Erica Finolezzi, Alice Di Rocco, Emanuele Del Fava, Luigi Rigacci, Simonetta Di Lollo, Alberto Bosi, Enrico Mini	4
15	Prognostic role of gender in diffuse large B-cell lymphoma treated with rituximab containing regimens: a Fondazione Italiana Linfomi/Grupo de Estudos em Moléstias Onco-Hematológicas retrospective study 2012 ·Leukemia & lymphoma ·Angelo Michele Carella, Cármino Antônio De Souza, Stefano Luminari, Luigi Marcheselli, Annalisa Chiappella, Alice Di Rocco, Marina Cesaretti, Andrea Rossi, Luigi Rigacci, Gianluca Gaïdano, Francesco Merli, Michele Spina, Caterina Stelitano, Stefan Hohaus, Anna Maria Barbui, Benedetta Puccini, Eliana Miranda, (unknown), Massimo Federico	36
16	Early interim 18F-FDG PET in Hodgkin’s lymphoma: evaluation on 304 patients 2011 ·European Journal of Nuclear Medicine and Molecular Imaging ·Pier Luigi Zinzani, Luigi Rigacci, Vittorio Stefoni, Alessandro Broccoli, Benedetta Puccini, Antonio Castagnoli, Luca Vaggelli, Lucia Zanoni, Lisa Argnani, Michele Baccarani, Stefano Fanti	82
17	Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients 2011 ·Leukemia Research ·Luigi Rigacci, (unknown), (unknown), Benedetta Puccini, Renato Alterini, Valentina Carrai, Tania Perrone, Alberto Bosi	9
18	Impact of Dose-Dense Immunochemotherapy on Prognosis of Germinal Center and Non Germinal Center Origin of Diffuse Large B Cell Lymphoma 2011 ·Journal of Chemotherapy ·Luigi Rigacci, Benedetta Puccini, Lorenzo Iovino, Maurizio Martelli, Erica Finolezzi, Simonetta Di Lollo, (unknown), Alberto Bosi	1
19	Oxaliplatin‐based chemotherapy (dexamethasone, high‐dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma 2010 ·Cancer ·Luigi Rigacci, Alberto Fabbri, Benedetta Puccini, (unknown), Annalisa Chiappella, Umberto Vitolo, Alessandro Levis, Francesco Lauria, Alberto Bosi	22
20	Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas 2007 ·Annals of Hematology ·Luigi Rigacci, Luca Nassi, (unknown), Silvia Mappa, Ennio Polito, (unknown), Renato Alterini, Valentina Carrai, Benedetta Puccini, Alberto Bosi	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact